ALS Limited

ALQ

AU000000ALQ6

Business Support Services

Market Closed - Australian S.E. Other stock markets 02:10:52 2024-04-24 am EDT			5-day change	1st Jan Change
13.37 ^AUD	+0.75%		+1.83%	+4.05%

Apr. 02	Morgans Financial Downgrades ALS to Hold from Add, Price Target at AU$13.70	MT
Mar. 26	Jarden Adjusts ALS's Price Target to AU$13.70 from AU$13.80, Keeps at Buy	MT

Tranche Update on ALS Limited's Equity Buyback Plan announced on November 20, 2017.

June 22, 2021 at 08:12 pm EDT

From October 1, 2020 to March 31, 2021, the company has repurchased 0 shares, representing 0% for AUD 0 million. With this, the company has completed the repurchase of 21,795,374 shares, representing 4.38% for AUD 153.4 million under the buyback announced on November 20, 2017.

Latest news about ALS Limited

Morgans Financial Downgrades ALS to Hold from Add, Price Target at AU$13.70	Apr. 01	MT
Jarden Adjusts ALS's Price Target to AU$13.70 from AU$13.80, Keeps at Buy	Mar. 25	MT
ALS to Acquire Nuvisan; Shares Down 5%	Mar. 24	MT
Transcript : ALS Limited, Nuvisan Pharma Holding Gmbh - M&A Call	Mar. 24
ALS Limited agreed to acquire YORK Analytical Laboratories, Inc.	Mar. 24	CI
ALS Limited agreed to acquire Wessling Holding Gmbh & Co.Kg.	Mar. 24	CI
ALS Limited agreed to acquire the remaining 51% stake in Nuvisan Pharma Holding Gmbh.	Mar. 24	CI
Jarden Adjusts ALS' Price Target to AU$13.80 From AU$13.40, Keeps at Buy	Mar. 21	MT
Rimfire Pacific Mining Completes Air Core Drilling at Murga Project	Mar. 17	MT
ALS Limited Appoints Stuart Hutton as Chief Financial Officer, Effective 1 February 2024	Dec. 19	CI
New entries in the Investor Asia portfolio	Dec. 14
Australian Shares Rise as Investors Await US Inflation Data for Rate Hike Clues	Nov. 14	MT
ALS Trims Interim Dividend as Fiscal H1 Profit Declines; CFO to Step Down; Shares Up 6%	Nov. 13	MT
Australian shares rise on broad-based gains; CBA inches higher	Nov. 13	RE
ALS Limited acquired 85.6% stake in Indtech Instruments Private Limited for AUD 18.6 million.	Nov. 13	CI
Transcript : ALS Limited, H1 2024 Earnings Call, Nov 14, 2023	Nov. 13
ALS Limited Announces Stepdown of Luis Damasceno as Chief Financial Officer, Effective 19 January 2024	Nov. 13	CI
ALS Limited Appoints Heike Truöl as Chief Strategy Officer	Nov. 13	CI
Als Limited Announces Interim Dividend for the Period of Six Months Ending 30 September 2023, Payable on 14 December 2023	Nov. 13	CI
ALS Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 13	CI
ALS Limited acquired 100% stake in Proanaliz Group of Laboratories for AUD 5.1 million.	23-08-08	CI
ALS Limited's Equity Buyback Plan Extended till August 27, 2024.	23-08-08	CI
ALS Limited To Seek Acquisitions	23-07-25	CI
Transcript : ALS Limited - Shareholder/Analyst Call	23-07-25
ALS Limited Announces Board Changes	23-06-06	CI

Chart ALS Limited

Duration

Period

More charts

Company Profile

ALS Limited is an Australia-based company that is engaged in the provision of professional technical services. The Company provides services primarily in the areas of testing, measurement and inspection, supporting environmental monitoring, food and pharmaceutical quality assurance, and mining and mineral exploration. The Companyâs segments include Commodities and Life Sciences. The Commodities segment provides assaying and analytical testing services and metallurgical services for mining and mineral exploration companies and provides specialist services to the coal industry, such as coal sampling, analysis and certification, formation evaluation services, tribology testing services and related analytical testing. The Life Sciences segment provides analytical testing data to assist consulting and engineering firms, industry, and governments around the world in making informed decisions about environmental, food and pharmaceutical, electronics, consumer products, and animal health.

Sector

Business Support Services

Calendar

2024-05-20 - Q4 2024 Earnings Release

Related indices

S&P/ASX 200

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ALS Limited : At the heart of industries under the microscope

May 03, 2023 at 11:34 am EDT

More Strategies

Ratings for ALS Limited

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

13.37 AUD

Average target price

12.85 AUD

Spread / Average Target

-3.86%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Business Support Services

	1st Jan change	Capi.
ALS LIMITED	+4.05%	4.2B
CINTAS CORPORATION	+10.43%	67.38B
JACOBS SOLUTIONS INC.	+10.49%	18.09B
RB GLOBAL, INC.	+9.73%	13.41B
BUREAU VERITAS SA	+19.46%	13.04B
INTERTEK GROUP PLC	+16.53%	9.92B
TELEPERFORMANCE SE	-33.68%	5.84B
GENPACT LIMITED	-11.47%	5.73B
MAXIMUS, INC.	-3.94%	4.93B
EXLSERVICE HOLDINGS, INC.	-5.92%	4.9B

Other Business Support Services

ALS Limited

Equities

ALQ

AU000000ALQ6

Business Support Services

Tranche Update on ALS Limited's Equity Buyback Plan announced on November 20, 2017.

EPS Revisions